Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Carlos Lopez-Gutierrez

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Interactive Cardiovascular and Thoracic Surgery|January 21, 2011
PHACES syndrome and ectopia cordisJuan Carlos Lopez-Gutierrez
Pediatric Blood & Cancer|May 9, 2023
Activity of a TIE2 inhibitor (rebastinib) in a patient with a life-threatening cervicofacial venous malformationPaloma Triana, Juan Carlos Lopez-Gutierrez
Archives of Facial Plastic Surgery|September 21, 2005
Giant rapidly involuting congenital hemangioma of the face: 15-year follow-upJuan Carlos Lopez-Gutierrez, Mercedes Diaz, Zoraida Ros
Pediatric Hematology and Oncology|September 25, 2010
Vincristine-ticlopidine-aspirin: an effective therapy in children with Kasabach-Merritt phenomenon associated with vascular tumorsIsrael Fernandez-Pineda, Juan Carlos Lopez-Gutierrez, Gema Ramirez, et al.
BMJ Case Reports|June 10, 2022
Thoracic venous malformation: a particular form of a visceral variantInês Pessanha, Paloma Triana, Victor Martinez-Glez, et al.
Pediatric Dermatology|April 7, 2017
Identical Presentation of Scapular Osteolysis in Two Patients with Thoracic Kaposiform HemangioendotheliomaVerónica Alonso Arroyo, Juan Carlos Lopez-Gutierrez, Rox Martinez, et al.
Biologics : Targets & Therapy|May 27, 2026
Long-Term TIE2 Inhibition in a TEK-Mutated Venous Malformation: A 3-Year Clinical ExperiencePaloma Triana, Elena Marín, Covadonga Mendieta, et al.
Pediatric Blood & Cancer|April 24, 2013
Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with Kasabach-Merritt phenomenonIsrael Fernandez-Pineda, Juan Carlos Lopez-Gutierrez, Gloria Chocarro, et al.
Annals of Vascular Surgery|July 25, 2022
Undergrowth Of First Toe In PiK3CA-Related Overgrowth Spectrum (PROS)Paloma Triana, María Del Carmen Sarmiento, Lara Rodriguez-Laguna, et al.
Journal of Pediatric Surgery|October 31, 2008
Neurofibromatosis type 1 with external genitalia involvement presentation of 4 patientsIgnacio Pascual-Castroviejo, Pedro Lopez-Pereira, Salvatore Savasta, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Interactive Cardiovascular and Thoracic Surgery|January 21, 2011
PHACES syndrome and ectopia cordisJuan Carlos Lopez-Gutierrez
Pediatric Blood & Cancer|May 9, 2023
Activity of a TIE2 inhibitor (rebastinib) in a patient with a life-threatening cervicofacial venous malformationPaloma Triana, Juan Carlos Lopez-Gutierrez
Archives of Facial Plastic Surgery|September 21, 2005
Giant rapidly involuting congenital hemangioma of the face: 15-year follow-upJuan Carlos Lopez-Gutierrez, Mercedes Diaz, Zoraida Ros
Pediatric Hematology and Oncology|September 25, 2010
Vincristine-ticlopidine-aspirin: an effective therapy in children with Kasabach-Merritt phenomenon associated with vascular tumorsIsrael Fernandez-Pineda, Juan Carlos Lopez-Gutierrez, Gema Ramirez, et al.
BMJ Case Reports|June 10, 2022
Thoracic venous malformation: a particular form of a visceral variantInês Pessanha, Paloma Triana, Victor Martinez-Glez, et al.
Pediatric Dermatology|April 7, 2017
Identical Presentation of Scapular Osteolysis in Two Patients with Thoracic Kaposiform HemangioendotheliomaVerónica Alonso Arroyo, Juan Carlos Lopez-Gutierrez, Rox Martinez, et al.
Biologics : Targets & Therapy|May 27, 2026
Long-Term TIE2 Inhibition in a TEK-Mutated Venous Malformation: A 3-Year Clinical ExperiencePaloma Triana, Elena Marín, Covadonga Mendieta, et al.
Pediatric Blood & Cancer|April 24, 2013
Long-term outcome of vincristine-aspirin-ticlopidine (VAT) therapy for vascular tumors associated with Kasabach-Merritt phenomenonIsrael Fernandez-Pineda, Juan Carlos Lopez-Gutierrez, Gloria Chocarro, et al.
Annals of Vascular Surgery|July 25, 2022
Undergrowth Of First Toe In PiK3CA-Related Overgrowth Spectrum (PROS)Paloma Triana, María Del Carmen Sarmiento, Lara Rodriguez-Laguna, et al.
Journal of Pediatric Surgery|October 31, 2008
Neurofibromatosis type 1 with external genitalia involvement presentation of 4 patientsIgnacio Pascual-Castroviejo, Pedro Lopez-Pereira, Salvatore Savasta, et al.
Pageof 3